Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  22 نتائج ل ""Transcriptional Regulator ERG""

فلترة النتائج

Publisher : biomed central
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A cross-sectional study of ERG expression and the relationship with clinicopathological features of Prostate cancer in Southwestern Uganda.

  • Authors : Mitala Y; Department of Pathology, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara City, Uganda. .; Ssenkumba B

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/epidemiology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/genetics

  • Source: Diagnostic pathology [Diagn Pathol] 2024 May 10; Vol. 19 (1), pp. 67. Date of Electronic Publication: 2024 May 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature.

  • Authors : Li Y; School of Biology and Engineering, Guizhou Medical University, Guiyang, Guizhou, China.; Su H

Subjects: Transcriptome* ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy; Male

  • Source: World journal of surgical oncology [World J Surg Oncol] 2024 Feb 09; Vol. 22 (1), pp. 49. Date of Electronic Publication: 2024 Feb 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Intercellular adhesion molecule 2 as a novel prospective tumor suppressor induced by ERG promotes ubiquitination-mediated radixin degradation to inhibit gastric cancer tumorigenicity and metastasis.

  • Authors : Tang X; Department of Gastrointestinal Surgery Section 2, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510655, China.

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/genetics; Humans ; Prospective Studies

  • Source: Journal of translational medicine [J Transl Med] 2023 Sep 27; Vol. 21 (1), pp. 670. Date of Electronic Publication: 2023 Sep 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.

  • Authors : Dadhania V; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Gonzalez D

Subjects: Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/diagnosis ; Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/genetics ; Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/pathology

  • Source: BMC cancer [BMC Cancer] 2022 May 05; Vol. 22 (1), pp. 494. Date of Electronic Publication: 2022 May 05.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Transcriptional landscape of PTEN loss in primary prostate cancer.

  • Authors : Imada EL; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. .; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .

Subjects: Gene Expression Regulation, Neoplastic* ; Transcriptome*; PTEN Phosphohydrolase/PTEN Phosphohydrolase/PTEN Phosphohydrolase/*metabolism

  • Source: BMC cancer [BMC Cancer] 2021 Jul 26; Vol. 21 (1), pp. 856. Date of Electronic Publication: 2021 Jul 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model.

  • Authors : Semaan L; Department of Urology, Wayne State University School of Medicine, 9245 Scott Hall, 540 E. Canfield Avenue, Detroit, MI, 48201, USA.; Mander N

Subjects: Androgen Receptor Antagonists*/Androgen Receptor Antagonists*/Androgen Receptor Antagonists*/therapeutic use ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/drug therapy ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/secondary

  • Source: BMC cancer [BMC Cancer] 2019 Oct 21; Vol. 19 (1), pp. 972. Date of Electronic Publication: 2019 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer.

  • Authors : Weidemann SA; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Sauer C

Subjects: Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*metabolism ; Protein Tyrosine Phosphatase, Non-Receptor Type 12/Protein Tyrosine Phosphatase, Non-Receptor Type 12/Protein Tyrosine Phosphatase, Non-Receptor Type 12/*metabolism; Aged

  • Source: BMC cancer [BMC Cancer] 2019 Oct 12; Vol. 19 (1), pp. 944. Date of Electronic Publication: 2019 Oct 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance.

  • Authors : Hashmi AA; Liaquat National Hospital and Medical College, Karachi, Pakistan.; Khan EY

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*biosynthesis ; Carcinoma, Acinar Cell/Carcinoma, Acinar Cell/Carcinoma, Acinar Cell/*metabolism ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*metabolism

  • Source: BMC research notes [BMC Res Notes] 2019 Jan 18; Vol. 12 (1), pp. 35. Date of Electronic Publication: 2019 Jan 18.Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.

  • Authors : Mancarella C; CRS Development of Biomolecular Therapies, Experimental Oncology Laboratory, Rizzoli Orthopedic Institute, via di Barbiano, 1/10, 40136, Bologna, Italy.; Casanova-Salas I

Subjects: Oncogene Proteins, Fusion*; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*metabolism ; Receptors, Somatomedin/Receptors, Somatomedin/Receptors, Somatomedin/*metabolism

  • Source: BMC cancer [BMC Cancer] 2017 May 25; Vol. 17 (1), pp. 367. Date of Electronic Publication: 2017 May 25.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

  • Authors : Tsourlakis MC; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Stender A

Subjects: Genetic Heterogeneity*; Oncogene Proteins, Fusion/Oncogene Proteins, Fusion/Oncogene Proteins, Fusion/*metabolism ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*surgery

  • Source: BMC cancer [BMC Cancer] 2016 Aug 17; Vol. 16, pp. 641. Date of Electronic Publication: 2016 Aug 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  22 نتائج ل ""Transcriptional Regulator ERG""